backgroundvirusinduc
inflamm
contribut
respiratori
syncyti
viru
rsv
pathogenesi
sought
determin
specif
mediat
associ
sever
ill
young
children
methodschildren
yr
age
seen
emerg
depart
respiratori
symptom
septemb
may
elig
enrol
nasopharyng
np
wash
sampl
collect
elig
patient
clinic
data
record
individu
includ
studi
np
wash
sampl
posit
rsv
patient
enrol
studi
stratifi
diseas
sever
defin
mild
hospit
moder
hospit
sever
requir
icu
stay
concentr
individu
inflammatori
biomark
np
wash
fluid
determin
use
luminex
human
assay
respiratori
syncyti
viru
rsv
infect
children
third
birthday
major
infect
mild
two
million
children
unit
state
requir
medic
attent
year
without
clear
underli
risk
factor
seriou
infect
known
risk
factor
sever
diseas
includ
prematur
congenit
heart
diseas
chd
underli
lung
diseas
includ
chronic
lung
diseas
prematur
immun
defici
syndrom
multipl
birth
neuromuscular
diseas
ii
iii
risk
factor
sever
ill
otherwis
healthi
children
born
term
includ
young
age
time
infect
iv
low
umbil
cord
blood
antirsv
neutral
antibodi
concentr
v
ethnic
background
vi
varieti
specif
gene
polymorph
vii
viru
characterist
may
also
contribut
diseas
sever
viii
specif
rsv
strain
alter
studi
candid
live
attenu
vaccin
reduct
nasal
wash
concentr
interferon
g
interleukin
observ
chang
peak
viru
replic
rsv
isol
divid
two
major
group
b
due
differ
amino
acid
sequenc
attach
g
protein
two
major
group
usual
circul
simultan
proport
infect
caus
group
b
virus
differ
season
season
ix
type
season
gener
sever
suggest
typespecif
differ
may
contribut
ill
sever
rsv
diseas
pathogenesi
depend
interplay
viral
replic
virusinduc
innat
inflammatori
respons
rsvinfect
cell
releas
mediat
recruit
inflammatori
cell
lung
magnitud
respons
shown
correl
ill
sever
sever
inflammatori
mediat
includ
x
xi
xii
xiii
xiv
xvxvi
xvii
xviii
xix
xx
explor
character
risk
factor
associ
ill
sever
rsv
infect
studi
includ
clinic
characterist
rsv
type
togeth
concentr
inflammatori
marker
detect
np
wash
children
year
age
period
sought
medic
care
infect
pediatr
emerg
depart
biomark
chosen
analysi
includ
mediat
alreadi
implic
ill
sever
refer
other
identifi
marker
infect
sever
cognat
model
sever
pneumoviru
infect
mice
xxi
septemb
may
child
year
younger
present
emerg
depart
elig
enrol
hesh
symptom
viral
respiratori
infect
includ
least
three
follow
fever
congest
cough
stridor
wheez
tachypnea
nasopharyng
np
wash
sampl
obtain
subject
standard
manner
xxii
portion
sampl
evalu
respiratori
viral
cultur
rapid
influenza
rsv
test
anoth
portion
divid
frozen
store
children
initi
consid
studi
found
cultureposit
rsv
patient
inform
collect
medic
record
includ
demograph
detail
regard
clinic
present
past
medic
histori
detail
regard
hospit
cours
admit
protocol
approv
suni
upstat
medic
univers
irbph
addit
obtain
inform
consent
nasal
wash
sampl
asymptomat
children
age
two
week
year
obtain
use
control
data
first
patient
also
use
control
group
previous
report
manuscript
parainfluenza
viru
infect
xxiii
age
gender
distribut
control
group
similar
research
subject
children
age
one
year
children
age
one
four
year
sixtyf
control
subject
male
nucleic
acid
extract
np
wash
sampl
enrol
patient
subject
virusspecif
amplif
luminex
respiratori
viru
panel
rvp
confirm
rsv
infect
determin
rsv
group
b
potenti
coinfect
statu
enteroviru
rhinoviru
human
metapneumoviru
adenoviru
coronaviru
parainfluenza
andor
influenza
b
sampl
document
posit
virus
rsv
exclud
subsequ
analysi
would
possibl
determin
coinfect
virus
might
contribut
express
pattern
induc
proinflammatori
mediat
patient
document
cultur
posit
bacteri
infect
exclud
aliquot
np
wash
obtain
patient
infect
rsv
alon
retriev
analysi
assay
perform
use
invitrogen
human
cytokin
panel
catalog
lot
luminex
platform
use
biorad
instrument
immunoassay
detect
interleukin
il
tumor
necrosi
factor
alpha
granulocyt
macrophag
coloni
stimul
factor
gmcsf
macrophag
inflammatori
protein
mip
induc
protein
ip
monokin
induc
gamma
interferon
mig
eotaxin
regul
upon
express
normal
tcell
express
secret
rant
macrophag
chemotact
protein
mcp
vascular
endotheli
growth
factor
vegf
granulocyt
coloni
stimul
factor
gcsf
epiderm
growth
factor
egf
basic
fibroblast
growth
factor
fgf
hepatocyt
growth
factor
hgf
biosourc
intern
camarillo
ca
sampl
store
thaw
room
temperatur
dilut
analysi
follow
twohour
incub
spectrallyencod
bead
coat
analytespecif
biotinyl
primari
antibodi
sampl
incub
streptavidin
rphycoerythrin
analyz
luminex
xmap
multiplex
system
luminex
corpor
austin
tx
protein
concentr
determin
bradford
microassay
bovin
serum
albumin
standard
concentr
inflammatori
mediat
report
herein
per
mg
total
protein
correct
differ
np
wash
collect
techniqu
xxiv
descript
purpos
patient
characterist
summar
percentag
mean
standard
error
variabl
log
transform
serious
skew
identifi
predictor
hospit
zero
inflat
neg
binomi
model
fit
conjunct
backward
model
select
procedur
consid
akaik
inform
criterion
either
two
sampl
ttest
one
way
anova
use
compar
profil
inflammatori
mediat
equal
test
varianc
group
valid
test
examin
nonparametr
altern
includ
kental
tau
multipl
test
correct
use
benjamini
hochberg
fals
discoveri
rate
adjust
appli
applic
enrol
patient
exclud
final
analysi
patient
return
ed
within
seven
day
emerg
depart
visit
anoth
either
document
bacteri
coinfect
second
respiratori
viru
grow
tissu
cultur
pcr
posit
viru
coinfect
rvp
evalu
patient
np
sampl
cultureposit
rsv
show
also
rvpposit
detect
rsvspecif
rna
one
addit
respiratori
virus
detect
sampl
yield
coinfect
rate
patient
rsv
detect
includ
subsequ
analys
result
rvp
analysi
indic
patient
infect
rsva
rsvb
annual
season
distribut
septmay
isol
base
rsv
type
decad
studi
shown
figur
nine
ten
consecut
season
infect
rsva
predomin
patient
mix
viral
infect
varieti
second
agent
detect
common
rhinoenteroviru
final
data
analysi
includ
patient
document
infect
rsv
median
age
patient
infect
rsv
month
rang
day
year
male
signific
prior
medic
histori
median
durat
symptom
prior
seek
medic
attent
day
rang
day
clinic
document
temperatur
c
patient
chest
radiograph
perform
normal
abnorm
radiograph
find
vari
wide
common
find
hyperinfl
therapeut
patient
receiv
system
glucocorticoid
treat
antibiot
although
none
patient
cohort
document
bacteri
infect
number
patient
treat
either
glucocorticoid
antibiot
differ
pre
post
public
american
academi
pediatr
guidelin
treatment
bronchiol
specif
recommend
routin
use
glucocorticoid
state
antibacteri
agent
use
coexist
bacteri
infect
xxv
total
patient
hospit
median
day
femal
male
major
treat
supplement
oxygen
intens
care
unit
stay
requir
hospit
patient
median
durat
day
hospit
associ
young
age
p
rsv
type
p
gender
household
exposur
cigarett
smoke
among
group
patient
patient
born
week
gestat
median
age
studi
entri
mo
patient
carri
diagnosi
chronic
lung
diseas
prematur
cldp
median
age
mo
patient
hemodynam
signific
underli
congenit
heart
diseas
chd
median
age
mo
patient
born
prematur
chd
never
receiv
prophylact
human
monoclon
antirsv
f
protein
palivizumab
expect
prematur
chd
cldp
repres
independ
risk
factor
ill
sever
p
separ
cochranarmitag
trend
test
ill
sever
np
wash
concentr
inflammatori
mediat
stratifi
ill
sever
three
group
mild
ill
defin
ill
requir
hospit
n
moder
ill
requir
hospit
intens
care
n
sever
ill
requir
intens
care
n
adjust
anova
across
three
ill
sever
group
reveal
ill
sever
mild
moder
sever
associ
increas
concentr
thirteen
inflammatori
marker
measur
includ
egf
hgf
tabl
egf
hgf
previous
identifi
biomark
diseas
sever
expect
compar
asymptomat
control
patient
mediat
report
tabl
express
higher
concentr
rsv
infect
cumul
logist
regress
model
demonstr
rsv
type
independ
predictor
hospit
p
next
determin
whether
nasopharyng
mediat
concentr
differ
respons
infect
rsv
type
compar
mediat
concentr
measur
patient
infect
rsv
type
test
reveal
significantli
higher
concentr
hgf
measur
np
wash
sampl
collect
patient
infect
rsva
adjust
p
mediat
measur
similar
rsv
b
infect
group
tabl
effect
prematur
chd
cldp
np
wash
mediat
concentr
also
assess
specif
differ
emerg
suggest
inflammatori
mediat
differenti
express
patient
three
risk
factor
similarli
exposur
household
cigarett
smoke
impact
pattern
detect
enrol
infant
histori
prematur
lower
concentr
p
similar
concentr
detect
inflammatori
mediat
data
shown
address
possibl
older
age
prior
ill
note
famili
record
medic
record
multipl
exposur
infect
rsv
past
season
presenc
underli
risk
factor
sever
rsv
diseas
influenc
find
entir
cohort
perform
subset
analysi
exclud
children
older
month
born
prematur
underli
ill
prior
studi
enrol
remain
group
includ
total
patient
male
among
hospit
hospit
requir
intens
care
requir
intens
care
month
previous
healthi
subgroup
popul
probabl
hospit
decreas
age
zeroinfl
neg
binomi
regress
result
show
hospit
durat
also
longer
younger
patient
amount
decreas
durat
hospit
age
month
doubl
hold
variabl
constant
contrast
older
patient
less
like
hospit
similar
cohort
patient
patient
moder
sever
diseas
subgroup
statist
higher
concentr
egf
hgf
np
wash
sampl
tabl
ttest
also
reveal
novel
find
hgf
concentr
np
wash
obtain
patient
subgroup
higher
infect
rsva
p
unlik
find
seen
entir
cohort
subgroup
popul
demonstr
statist
higher
concentr
hgf
egf
p
infect
rsva
inflammatori
concentr
continu
similar
infect
rsva
rsvb
tabl
known
risk
factor
sever
rsv
diseas
includ
young
age
prematur
cldp
underli
chd
neuromuscular
disord
syndrom
otherwis
healthi
infant
less
commonli
develop
sever
infect
usual
unclear
predispos
risk
work
evalu
potenti
risk
factor
moder
hospit
sever
icu
ill
cohort
children
year
age
younger
alreadi
seek
medic
attent
emerg
depart
rsv
infect
confirm
young
age
prematur
cldp
chd
independ
associ
moder
sever
ill
explor
whether
infect
rsv
type
andor
np
inflammatori
respons
rsv
infect
determin
sampl
obtain
time
present
could
identifi
novel
marker
ill
sever
relationship
rsv
type
ill
sever
focu
sever
publish
studi
evalu
patient
season
xxvi
reveal
strongli
domin
rsva
strain
year
associ
higher
proport
rsv
admiss
requir
intens
care
vs
possibl
also
rais
rsv
viral
load
predict
ill
sever
hall
colleagu
xxxi
first
rais
possibl
studi
daili
nasal
wash
sampl
infant
found
rsv
load
significantli
higher
rsv
shed
prolong
infant
lower
respiratori
ill
similarli
buckingham
et
al
xxxii
show
rsv
viral
load
higher
ventil
patient
compar
nonventil
hospit
patient
find
recent
mirror
scagnolari
et
al
xxxiii
el
saleebi
et
al
xxxiv
evalu
children
less
year
age
rsv
season
show
rsv
load
dynam
viru
clearanc
highli
predict
ill
sever
rsv
also
known
complex
effect
epitheli
cell
gene
express
result
releas
inflammatori
mediat
date
limit
number
infant
studi
describ
small
cohort
patient
suggest
np
concentr
patient
ventil
ventil
children
patient
hypoxem
bronchiol
hospit
children
infant
ventil
correl
sever
infant
rsv
ill
larg
cohort
rsvinfect
children
confirm
find
previous
publish
smaller
studi
addit
found
previous
known
induc
rsv
infect
ad
grow
list
mediat
associ
rsv
ill
sever
tabl
note
et
al
xxxv
evalu
patient
rsv
bronchiol
found
posit
correl
nasopharyng
concentr
ill
sever
invers
relationship
sever
mediat
includ
sever
identifi
herein
clear
marker
ill
sever
possibl
explan
differ
found
studi
includ
small
number
patient
evalu
garcia
studi
broader
spectrum
clinic
ill
includ
work
among
promin
find
studi
novel
observ
np
concentr
hgf
egf
correl
ill
sever
infect
rsvtype
find
previous
report
hgf
produc
lung
alveolar
macrophag
endotheli
cell
bronchial
cell
fibroblast
signal
via
receptor
cmet
express
endotheli
epitheli
cell
xxxvi
signal
transduct
hgf
promot
normal
tissu
regener
prevent
fibrot
remodel
follow
injuri
xxxvii
studi
hgf
context
viral
lung
infect
limit
observ
narasaraju
et
al
xxxviii
demonstr
immunolog
blockad
signal
influenza
infect
result
impair
hgf
express
augment
lung
injuri
treatment
exogen
enhanc
hgf
express
result
reduc
lung
injuri
specif
role
hgf
overexpress
moder
sever
rsv
infect
remain
defin
correl
ill
sever
hgf
concentr
known
biolog
function
factor
suggest
produc
protect
mechan
rather
contribut
directli
diseas
pathogenesi
similarli
egf
known
particip
lung
epitheli
cell
growth
repair
xxxix
receptor
egfr
shown
interact
directli
rsv
xl
influenza
viru
xli
specif
role
follow
viral
infect
lung
remain
explor
major
strength
work
character
risk
factor
associ
ill
sever
larg
cohort
infant
young
children
infect
rsv
coinfect
respiratori
virus
bacteri
pathogen
exclud
strategi
use
previous
mention
report
rsv
ill
sever
mirror
strategi
use
studi
adenoviru
parainfluenza
viru
pathogenesi
xlii
find
confirm
young
age
hospit
predictor
diseas
sever
youngest
patient
hospit
longest
durat
moreov
present
evid
support
hypothesi
rsva
infect
sever
caus
rsvb
found
direct
associ
np
wash
concentr
differ
inflammatori
mediat
ill
sever
five
previous
report
associ
sever
rsv
diseas
final
report
first
time
hgf
egf
factor
known
import
lung
remodel
repair
express
respiratori
secret
higher
concentr
sever
rsv
diseas
specif
infect
rsva
find
worthi
character
shown
distribut
infect
rsv
type
black
b
gray
consecut
year
enrol
tabl
nasal
wash
cytokin
concentr
ngmlmg
protein
sem
detect
asymptomat
control
patient
rsvinfect
patient
concentr
interferon
gmcsf
eotaxin
vegf
fgf
consist
level
detect
multipl
test
correct
use
benjamini
hochberg
fals
discov
rate
adjust
tabl
nasopharyng
wash
cytokin
concentr
ngmlmg
protein
sem
detect
rsva
rsvb
infect
patient
entir
cohort
previous
healthi
one
year
age
studi
enrol
concentr
interferon
gmcsf
eotaxin
vegf
fgf
consist
level
detect
multipl
test
correct
use
benjamini
hochberg
fals
discov
rate
adjust
